Cargando…
COVID-19 and thrombotic complications—the role of anticoagulants, antiplatelets and thrombolytics
Coronavirus disease 2019 (COVID-19) is a global pandemic the world is dealing with currently. Clinical evidences suggest that the patients are predisposed to both venous and arterial thrombotic complications. This is because of severe inflammatory responses, injury to endothelium and activation of p...
Autores principales: | Khandelwal, Gaurav, Ray, Avik, Sethi, Samdish, Harikrishnan, H. K., Khandelwal, Chaitanya, Sadasivam, Balakrishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653484/ https://www.ncbi.nlm.nih.gov/pubmed/34934647 http://dx.doi.org/10.4103/jfmpc.jfmpc_1297_20 |
Ejemplares similares
-
A Cost Variation Analysis of Drugs Available in the Indian Market for the Management of Thromboembolic Disorders
por: Ray, Avik, et al.
Publicado: (2020) -
Ticagrelor-Induced Prolongation of the QTc Interval
por: Ray, Avik, et al.
Publicado: (2019) -
Metformin in COVID-19: A possible role beyond diabetes
por: Sharma, Swati, et al.
Publicado: (2020) -
Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications
por: Schrottmaier, Waltraud C., et al.
Publicado: (2022) -
Bioactive Natural Compounds with Antiplatelet and Anticoagulant Activity and Their Potential Role in the Treatment of Thrombotic Disorders
por: Lamponi, Stefania
Publicado: (2021)